Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) EPS (Weighted Average and Diluted) (2021 - 2023)

Item 9 Labs' EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.06 for Q2 2023.

  • For Q2 2023, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.06; the TTM value through Jun 2023 reached -$0.32, down 28.0%, while the annual FY2022 figure was -$0.33, 135.71% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.06 in Q2 2023 per INLB's latest filing, down from -$0.03 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q1 2021 to a low of -$0.2 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.06, with a median of -$0.04 recorded in 2021.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 25.0% in 2022 against a maximum downside of 7030.9% in 2022.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.04 in 2021, then grew by 25.0% to -$0.03 in 2022, then plummeted by 100.0% to -$0.06 in 2023.
  • Per Business Quant, the three most recent readings for INLB's EPS (Weighted Average and Diluted) are -$0.06 (Q2 2023), -$0.03 (Q1 2023), and -$0.03 (Q4 2022).